Medical oncology Department, University Military Hospital of Instruction, Rabat, Morocco.
BMC Womens Health. 2011 Jun 13;11:29. doi: 10.1186/1472-6874-11-29.
This exploratory prospective study evaluated women's responses to questions that asked them to describe how their body image and sexual functioning had changed since their breast cancer diagnosis to treatment.
A questionnaire concerning body image scale and various sexual problems experienced after diagnosis and treatment was anonymously completed by 120 women in the outpatient clinic of our hospital's Division of medical Oncology. To be eligible, subjects had to be sexually active and had histology proven breast cancer. They also had to have received treatment for breast cancer.
100% of participants have never spoken with their doctor about this subject. 84% of the participants continued sexual activity after treatment, but there was an increase in the incidence of sexual functioning problems which resulted in a slight reduction in the quality of their sex lives. 65% of the women experienced dyspareunia followed by lubrication difficulties (54%) and the absence or reduction of sexual desire (48% and 64%, respectively) while, 37% had lack of satisfaction (37%). Female orgasmic disorder and brief intercourse and arousal were reported respectively by 40% and 38% of the subjects. The sexual dysfunctions were absent before diagnosis and management of breast cancer in 91.5% subjects and of these 100% subjects complained of a deterioration of the symptomatology after the various treatments. 90% of the dysfunctions were observed after chemotherapy, 9% after surgery and 3% after radiotherapy; none of the subjects indicated the onset of dysfunctions to have been associated with hormonotherapy. 100% expressed not having received sufficient information about how the disease and treatment (including surgery) might affect their sexual life.
Breast cancer and its treatment may result in significant difficulties with sexual functioning and sexual life. Addressing these problems is essential to improve the quality of life of Moroccan women with breast cancer.
本探索性前瞻性研究评估了女性对以下问题的反应：自乳腺癌诊断到治疗期间，她们的身体形象和性功能如何变化。
我们医院肿瘤内科门诊的 120 名女性匿名完成了一份关于身体形象量表和各种诊断和治疗后出现的性问题的问卷。符合条件的受试者必须有性生活，并且有组织学证实的乳腺癌。她们还必须接受过乳腺癌治疗。
100%的参与者从未就这个问题与医生交谈过。84%的参与者在治疗后继续进行性生活，但性功能问题的发生率增加，导致性生活质量略有下降。65%的女性出现性交疼痛，其次是润滑困难（分别为 54%和 48%）和性欲缺失或减少（分别为 48%和 64%），而 37%的女性感到不满意（37%）。40%的女性出现女性性高潮障碍，38%的女性出现短暂的性交和性唤起。91.5%的女性在诊断和管理乳腺癌前没有性功能障碍，其中 100%的女性抱怨各种治疗后症状恶化。90%的性功能障碍发生在化疗后，9%发生在手术后，3%发生在放疗后；没有受试者表示性功能障碍的发生与激素治疗有关。100%的女性表示没有收到关于疾病和治疗（包括手术）如何影响她们性生活的足够信息。
乳腺癌及其治疗可能导致显著的性功能和性生活困难。解决这些问题对于提高摩洛哥乳腺癌女性的生活质量至关重要。
